about
Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradationTopors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loopHigh mobility group protein-1 (HMG-1) is a unique activator of p53MDMX regulation of p53 response to ribosomal stressThe subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell linesThe Mdm2 oncoprotein interacts with the cell fate regulator NumbThe death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis.Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formationMDM2 suppresses p73 function without promoting p73 degradationTwo cellular proteins that bind to wild-type but not mutant p53Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibitionThe ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexesA TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback controlInvolvement of the DNA repair protein hHR23 in p53 degradationActivation of p53 in cervical carcinoma cells by small molecules.Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapyRegulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogeneA positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidizationNucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathwayTumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signalingDeubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1c-Src and neural Wiskott-Aldrich syndrome protein (N-WASP) promote low oxygen-induced accelerated brain invasion by gliomasIn vitro selection of mutant HDM2 resistant to Nutlin inhibitionNucleolar proteins suppress Caenorhabditis elegans innate immunity by inhibiting p53/CEP-1Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMXp14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicaseActivity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligaseMDM2 interacts with MDMX through their RING finger domainsThe double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitroAn N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoPhysical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblastsMDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation
P2860
Q22009163-6415A7EF-8856-4312-A01B-CA7E8AEA4413Q24290708-8268115A-5C90-4DB8-8729-5E79ACBE9FE2Q24292352-458658DF-991F-4C24-906F-F0CCA19E904CQ24298615-76083E0C-F760-415A-84ED-FE3EEF92B96FQ24298622-B4D3C626-8552-4D56-88A0-F7AA5B955522Q24299024-7707BA2F-7CBF-4890-B684-6E6A67CCA256Q24306287-3E2487F4-EBB5-436C-BB0C-2CF3B074035FQ24310683-F08E17E3-3F45-4600-B3BB-A5A991551255Q24311393-05DF853C-B341-4E3E-9038-5D17FF38C1BEQ24316958-599BA6ED-E266-412B-9481-0AF0889737F8Q24337220-BB655F93-3425-439B-9D63-1BC43F224A51Q24522545-ECF4ECC5-6FE3-4FB7-A561-237D4C296190Q24535515-EDF9C2D6-5627-44A9-992C-5597ABDA2AFFQ24537692-B6E4BB91-23DB-439D-9C44-53A118EC12CBQ24554510-E8A98021-85CC-48E7-A3F4-9C04C86D4A68Q24562261-EAEC51CD-CCC3-4DF0-8192-F6BC0670A930Q24562892-5DA4AC4F-4AA8-44CC-B3A8-E4DB9F202507Q24608783-9EC53C8C-5348-4834-9F36-45E2482F1881Q24621472-8E1C359A-B40D-418B-A8E2-0C1E799059E9Q24633456-2ADF3104-B48D-422D-9866-915F6BA52E49Q24644964-86F97989-5AF7-4B86-9941-7A73FF57E894Q24651380-D49F64D6-0CD6-4450-B7E2-9CE05F98972DQ24655012-57C7E818-9B3E-4293-8E3B-C5B167523B10Q24669694-78DE059A-BA15-4DA4-AE33-15EFBD2FBAFDQ24672736-13CAF0A5-F5D5-4A2F-A95A-12E35CD43011Q25255608-96207E92-30CE-44DE-86FE-32C00A4A1263Q26992094-078E46FA-23A6-4CE9-9B94-F1112CEC0CDBQ27003153-29FD01C4-44CA-4CFF-A1D4-EEF6B9F38682Q27305310-22E50455-261D-4105-BB4C-88EBDAC0F5D4Q27322456-5DC8E9D9-2976-44D1-92AE-0F6E9BAFD041Q27349004-2E3DC1FB-7DD5-46DE-A2E8-03126ACB19DEQ27658148-76B72F07-AF57-402B-B5CF-6935A1C7385AQ28115495-E4762888-A575-4A38-8105-AF9FFB773318Q28139082-7D0BD0E9-839A-4382-ACA4-580374747801Q28142437-D8ED536C-5F2C-4FD8-BC5E-51210C228E1DQ28144828-B33FD4EB-7F56-4B40-A1E6-E7A880AF9DDFQ28144965-58CF87EB-8F1F-448D-9918-87FB025F4717Q28198423-8C0EBA80-AD53-48A8-9A19-EF5795A03F90Q28200748-4F9FC021-62E9-4013-B654-6D270AFCF58DQ28204918-81743D33-8A8D-49B1-A952-EB9ECE06A24C
P2860
description
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
im Juli 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/07/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/07/01)
@nl
наукова стаття, опублікована в липні 1993
@uk
مقالة علمية (نشرت في يوليو 1993)
@ar
name
Mapping of the p53 and mdm-2 interaction domains
@ast
Mapping of the p53 and mdm-2 interaction domains
@en
Mapping of the p53 and mdm-2 interaction domains
@nl
type
label
Mapping of the p53 and mdm-2 interaction domains
@ast
Mapping of the p53 and mdm-2 interaction domains
@en
Mapping of the p53 and mdm-2 interaction domains
@nl
prefLabel
Mapping of the p53 and mdm-2 interaction domains
@ast
Mapping of the p53 and mdm-2 interaction domains
@en
Mapping of the p53 and mdm-2 interaction domains
@nl
P2093
P2860
P3181
P356
P1476
Mapping of the p53 and mdm-2 interaction domains
@en
P2093
A. J. Levine
V. Marechal
P2860
P304
P3181
P356
10.1128/MCB.13.7.4107
P407
P577
1993-07-01T00:00:00Z